Marco Herling
University of Cologne(DE)Saxon Academy of Sciences and Humanities in Leipzig(DE)Saxon Academy of Sciences in Leipzig(DE)Düsseldorf University Hospital(DE)Integrated Oncology (United States)(US)Comprehensive Cancer Center Mainfranken(DE)University Hospital Leipzig(DE)Jena University Hospital(DE)University Hospital Cologne(DE)Heinrich Heine University Düsseldorf(DE)Leipzig University(DE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Immune Cell Function and Interaction, Cutaneous lymphoproliferative disorders research
Most-Cited Works
- → Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial(2015)692 cited
- → Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia(2014)252 cited
- → Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity(2013)219 cited
- → A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories(2004)206 cited
- → TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin(2003)182 cited
- → CD4+/CD56+ Hematodermic Tumor(2007)172 cited